share_log

Stephens & Co. Reiterates Equal-Weight on Anika Therapeutics, Maintains $22 Price Target

Moomoo 24/7 ·  Mar 14 09:55

Stephens & Co. analyst George Sellers reiterates Anika Therapeutics (NASDAQ:ANIK) with a Equal-Weight and maintains $22 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment